Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small-cell lung carcinoma

Cancer Immunology Immunotherapy

Volumn 48, Issue 11, 2000, Pages 627-634

  Ortegel, John W ^a   Staren, Edgar D ^a   Faber, L P ^a   Warren, William H ^a   Braun, Donald P ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Flow cytometry; Intracellular cytokines; Non small cell lung carcinoma; Tumor infiltrating lymphocytes

Indexed keywords

CD3 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LUNG NON SMALL CELL CANCER; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0033956243     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050011     Document Type: Article

References (50)

1. 1. Aoki Y, Takakuwa K, Kodama S, Tanuka K, Takahashi H, Tokunaga A, et al (1991) Use of adoptive transfer of tumorinfiltrating lymphocytes alone or in combination with cisplatin containing chemotherapy in patients with epitelial ovarian cancer. Cancer Res 51:1934
2. 2. Asselin-Paturel C, Echchakir H, Carayol G, Gay F, Opolon P, Grunenwald D, Chouaib S, Mami-Chouaib F (1998) Quantitative analysis of Th1, Th2 and TGF-B1 cytokine expression in tumor, TIL, and PBL of non-small cell lung cancer patients. Int J Cancer 77:7
3. 3. Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD (1995) IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol 154:1280
4. 4. DeWaal-Malefyt R, Abrams J, Bennet B, Figdor C, DeVries J (1991) IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209
5. 5. DeWaal-Malefyt R, Haanen J, Spits H, Roncarlo MG, Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, DeVries JE (1991) Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-presenting human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 174:915
6. 6. Dillman RO, Seagren SL, Herndon J (1990) A randomized trial of induction chemotherpy plus high dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323:940
7. 7. Dillman RO, Oldham RK, Barth NM, Cohen RJ, Minor DR, Birch R, et al (1991) Continuous interleukin-2 and tumorinfiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial. Cancer 68:1
8. 8. Faber LP (1991) Lung Cancer: In: Holleb AI, Fink DJ, Murphy GP (eds) American Cancer Society textbook of clinical oncology. American Cancer Society, Atlanta, Ga, p 194
9. 9. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A (1991) IL10 acts on the antigenpresenting cell to inhibit cytokine production Th1 cells. J Immunol 146:3444
10. 10. Fischer JR, Schindel M, Stein N, Lahm H, Gallati H, Krammer PH, Drings P (1995) Selective suppression of cytokine secretion in patients with small-cell lung cancer. Ann Oncol 6:921
11. 11. Haskill S (1982) Some historical perspectives on the relationship between survival and mononuclear cell infiltration. In: Haskill S (ed) Tumour immunity and prognosis. The role of mononuclear cell infiltration. Dekker, New York, p 1
12. 12. Huang M, Wang PL, Sharma S, Mao J, Meissner H, Uyemura K, Modlin R, Wollman J, Dubinett S (1995) Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 55:3847
13. 2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol 157:5512
14. 14. Jung T, Schauer U, Heusser C, Neumann C, Rieger C (1993) Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159:197
15. 15. Kazuyuki T, Mostowski H, Tosato G (1993) Human interleukin-10 can directly inhibit T-cell growth. Blood 81:2964
16. 16. Kradin RL, Kurnick JT, Lazarus DS, Preffer FI, Dubinatt SM, Pinto CE, et al (1989) Tumor-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet 18:5770
17. 17. Mosmann TR, Moore KW (1991) The role of IL10 in cross-regulation of Th1 and Th2 responses. Immunol Today 12:A49
18. 18. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348
19. 19. Mountain CF (1986) A new international staging system for lung cancer. Chest 89:225S
20. 20. North RJ, Awwad JM, Dunn P (1989) The immune response to tumors. Transplant Proc 21:575
21. 21. Old LJ (1985) Tumor necrosis factor (TNF). Science 230:630
22. 22. Prussin C, Metcalfe D (1995) Detection of intracytoplasmic cytokines using flow cytometry and directly conjugated anticytokine antibodies. J Immunol Methods 188:117
23. 23. Rabinowich H, Cohen R, Bruderman I, Steiner Z, Klajman A (1987) Functional analysis of mononuclear cells infiltrating into tumors:lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res 47:173
24. 24. Ratto GB, Melioli G, Zino P, Mereu C, Mirabelli S, Fantino G, et al (1995) Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III Non-Small Cell Lung Cancer: a pilot study. J Thorac Cardiovasc Surg 109:1212
25. 25. Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1979) A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol 123:1312
26. 26. Romagnani S (1991) Human Th1 and Th2 subsets: doubt no more. Immunol Today 12:256
27. 27. Romagnani S (1991) Type 1 T helper and type 2 T helper cells: functions, regulation, and role in protection and disease. Int J Clin Lab Res 21:152
28. 28. Rosell R, Gomez-Codina J, Camps C (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330:153
29. 29. Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, et al (1988) Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminary report. N Engl J Med 319:1676
30. 30. Roth JA, Fossella F, Komaki R (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 330:153
31. 31. Rubbert A, Manger B, Lang N, Kalden JR, Platzer E (1991) Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes, and peripheral blood lymphocytes from patients with breast cancer. Int J Cancer 49:25
32. 32. Sander B, Andersson J, Andersson U (1991) Assessment of cytokines by immunoflourescence and the paraformaldehydesaponin procedure. Immunol Rev 119:65
33. 33. Schottenfeld D, Pass HI, Mitchell JB, Johnson DH, Turrisi AT (1996) Epidemology of lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT (eds) Lung cancer, principles and practice, 1st edn. Lippincott-Raven, Philadelphia, p 305
34. 34. Staren ED, Economou SG, Harris JE, Braun DP (1989) Lymphokine-activated killer cell induction in tumor-infiltrating leukocytes from colon cancer patients. Cancer 64:2238
35. 35. Stotter H, Wiebke EA, Tomita S, Belldgrun A, Topalian S, Rosenberg SA, Lotze MT Cytokines alter target cell susceptibility to lysis. J Immunol 142:1767
36. 36. Takizawa H, Ohtoshi T, Ohta K, Yamashita N, Hirohata S, Hirai K, Hiramatsu K, Ito K (1993) Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. Cancer Res 53:4175
37. 37. Tartakoff AM (1983) Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32:1026
38. 38. Underwood JCE (1974) Lymphoreticular infiltration in human tumors: prognostic and biological implications: a review. Br J Cancer 30:538
39. 39. Viale M, Ferrini S, Serrano S, Serrano D, Ardizzoni A, Nicolin A (1990) Peripheral blood and tumor infiltrating lymphocytes in non-small cell lung cancer: analysis at the population and clonal level. Tumori 76:488
40. 40. Vose BM (1980) Separation of tumor and host cell populations from human neoplasms: In: Reid E (ed) Methodol surveys in biochemistry and analysis, vol 11. Ellis Harwood, Chichester, p 45
41. 41. Vose BM, Moore M (1985) Human tumor-infiltrating lymphocytes: a marker of host response. Semin Hematol 22:27
42. 42. Wang P, Wu P, Siegel MI, Egan RW, Billah MM (1994) IL-10 inhibits transcription of cytokine genesin human peripheral blood mononuclear cells. J Immunol 153:811
43. 43. Whiteside TL, Miesher S, Hurlimann J, Moretta L, Von Fliedner V (1986) Separation, phenotyping and limiting-dilution analysis of T lymphocyte infiltrating human solid tumors. Int J Cancer 37:803
44. 44. Whiteside TL, Jost LM, Herbermann RB (1992) Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy. Crit Rev Oncol Hematol 12:25
45. 45. Wong PY, Staren ED, Tereshkova N, Braun DP (1998) Functional analysis of tumor-infiltrating leukocytes in breast cancer patients. J Surg Res 76:95
46. 46. Yamamura M, Modlin RL, Ohmen JD, Moy R (1993) Local expression of anti-inflammatory cytokines in cancer. J Clin Invest 91:1005
47. 47. Yoshino I, Tokujiro Y, Mitsuhiro M, Ishida T, Sugimachi K, Kimura G, Nomoto K (1992) Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res 52:775
48. 48. Yoshino I, Yano T, Murata M, Miyamoto M, Ishida T, Sugimachi K, Kimura G, Nomoto K (1993) Phenotypes of lymphocytes infiltrating non-small cell lung cancer tissues and its variation with histological types of cancer. Lung Cancer 10:13
49. 49. Yron I, Wood TA Jr, Spiess PJ, Rosenberg SA (1980) In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. J Immunol 125:238
50. 50. Zurawski G, de Vries JE (1994) Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15:19